New combo therapy aims to wipe out melanoma before It's cut out
NCT ID NCT04526730
Summary
This study tested a two-part immunotherapy for people with advanced melanoma that could still be removed by surgery. The goal was to see if giving a new drug (Tavo) injected directly into the tumor, along with a standard immunotherapy (nivolumab) given by IV, before surgery could shrink or eliminate the cancer. Researchers then checked if the tumor was gone after surgery and monitored patients to see if the cancer came back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.